This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Medimmune Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Martin Schwickart: Innovator in Antibody Development
Introduction
Martin Schwickart is a notable inventor based in Oakland, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on addressing diseases associated with interleukin-18, a cytokine involved in inflammatory responses.
Latest Patents
Schwickart holds a patent for "Anti-IL-18 antibodies and their uses." This invention provides human, humanized, and/or chimeric antibodies, along with fragments, derivatives, conjugates, and compositions that specifically bind to interleukin-18. The patent outlines the use of these antibodies for diagnosing and treating diseases linked to increased IL-18 activity, particularly in the form of a pharmaceutical composition.
Career Highlights
Martin Schwickart is currently associated with MedImmune Limited, a leading biotechnology company. His role involves research and development in the field of therapeutic antibodies, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Schwickart has collaborated with esteemed colleagues, including Claire Louise Dobson and Steven Godfrey Lane. These partnerships have fostered innovation and enhanced the development of new therapeutic solutions.
Conclusion
Martin Schwickart's work in antibody development exemplifies the impact of innovative research in biotechnology. His contributions are paving the way for new treatments that address critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile